Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PLGLB2 anticorps

Cet anticorps Lapin Polyclonal détecte spécifiquement PLGLB2 dans ELISA et IHC. Il présente une réactivité envers Humain.
N° du produit ABIN7246427

Aperçu rapide pour PLGLB2 anticorps (ABIN7246427)

Antigène

Voir toutes PLGLB2 Anticorps
PLGLB2 (Plasminogen-Like B2 (PLGLB2))

Reactivité

  • 12
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 10
  • 2
Lapin

Clonalité

  • 10
  • 2
Polyclonal

Conjugué

  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp PLGLB2 est non-conjugé

Application

  • 5
  • 2
  • 2
  • 2
  • 1
ELISA, Immunohistochemistry (IHC)
  • Attributs du produit

    Polyclonal Antibody

    Purification

    Antigen affinity purification

    Immunogène

    Fusion protein of human PLGLB2

    Isotype

    IgG
  • Indications d'application

    IHC 1:50-1:300, ELISA 1:5000-1:10000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1.14 mg/mL

    Buffer

    PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène

    PLGLB2 (Plasminogen-Like B2 (PLGLB2))

    Autre désignation

    PLGLB2

    Sujet

    Cleavage of the serine proteinase plasminogen to form plasmin is the central event in the dissolution of blood clots by the fibrinolytic system. Within the fibrinolytic cascade, the serine proteinases urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) activate the proenzyme plasminogen by cleaving plasminogen to form the fibrinolytically active enzyme plasmin. PLGLB2 (plasminogen-like B2), also known as PLGP1, is a 96 amino acid protein that resembles the N-terminal plasminogen activation peptide, which is released from plasminogen during conversion to plasmin. PLGLB2 may bind to lysine binding sites present in the kringle structures of plasminogen, an event that interfers with the binding of fibrin or α-2 antiplasmin to plasminogen and may result in the localization of activity at sites necessary for extracellular matrix destruction.

    UniProt

    Q02325
Vous êtes ici:
Chat with us!